Thomas Berg

634 total citations
5 papers, 189 citations indexed

About

Thomas Berg is a scholar working on Hepatology, Rheumatology and Infectious Diseases. According to data from OpenAlex, Thomas Berg has authored 5 papers receiving a total of 189 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Hepatology, 2 papers in Rheumatology and 1 paper in Infectious Diseases. Recurrent topics in Thomas Berg's work include Systemic Lupus Erythematosus Research (2 papers), Hepatitis C virus research (2 papers) and Liver Diseases and Immunity (1 paper). Thomas Berg is often cited by papers focused on Systemic Lupus Erythematosus Research (2 papers), Hepatitis C virus research (2 papers) and Liver Diseases and Immunity (1 paper). Thomas Berg collaborates with scholars based in Germany and Norway. Thomas Berg's co-authors include Hilde Berner Hammer, Espen A. Haavardsholm, Albrecht Stoehr, G Teuber, Stefan Mauss, Bettina König, Andreas Pangerl, Claus Niederau, D. Huhn and Heiner Wedemeyer and has published in prestigious journals such as Journal of Hepatology, Annals of the Rheumatic Diseases and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Thomas Berg

4 papers receiving 187 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Berg Germany	3	125	56	46	33	32	5	189
P. Bélénotti France	5	25 0.2×	40 0.7×	37 0.8×	44 1.3×	9 0.3×	19	139
Mélanie Gilson France	8	97 0.8×	7 0.1×	22 0.5×	81 2.5×	19 0.6×	9	176
Enrique Faugier Fuentes Mexico	7	82 0.7×	5 0.1×	22 0.5×	36 1.1×	48 1.5×	27	153
Damien Van Gysel France	7	51 0.4×	4 0.1×	40 0.9×	56 1.7×	6 0.2×	14	183
Marietta DeGuzman United States	8	40 0.3×	5 0.1×	21 0.5×	19 0.6×	11 0.3×	15	96
K. Lévesque France	6	95 0.8×	7 0.1×	7 0.2×	14 0.4×	22 0.7×	8	131
Baptiste Glace France	5	89 0.7×	3 0.1×	13 0.3×	53 1.6×	12 0.4×	9	164
Arani Sridhar United Kingdom	7	28 0.2×	3 0.1×	18 0.4×	45 1.4×	7 0.2×	17	127
Hasan Ahmad Hasan Albitar United States	8	7 0.1×	20 0.4×	24 0.5×	61 1.8×	20 0.6×	31	181
P. Sarliève France	10	15 0.1×	38 0.7×	51 1.1×	221 6.7×	4 0.1×	27	287

Countries citing papers authored by Thomas Berg

Since Specialization

Citations

This map shows the geographic impact of Thomas Berg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Berg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Berg more than expected).

Fields of papers citing papers by Thomas Berg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Berg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Berg. The network helps show where Thomas Berg may publish in the future.

Co-authorship network of co-authors of Thomas Berg

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Berg. A scholar is included among the top collaborators of Thomas Berg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Berg. Thomas Berg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Petroff, David, Jörn M. Schattenberg, S Zeuzem, et al.. (2025). Evaluating Resmetirom Eligibility Among Patients with MASH: Insights from the German Steatotic Liver Disease-Registry. Zeitschrift für Gastroenterologie. 63(8). 836–843. 1 indexed citations

2.

Petroff, David, Jörn M. Schattenberg, S Zeuzem, et al.. (2025). SAT-418-YI Indication of resmetirom in patients with metabolic dysfunction associated steatohepatitis in the real-world setting - data from the german SLD-registry. Journal of Hepatology. 82. S627–S628.

3.

Berg, Thomas, Albrecht Stoehr, G Teuber, et al.. (2019). Real‐world effectiveness and safety of glecaprevir/pibrentasvir for the treatment of chronic hepatitis C infection: data from the German Hepatitis C‐Registry. Alimentary Pharmacology & Therapeutics. 49(8). 1052–1059. 54 indexed citations

4.

Hammer, Hilde Berner, et al.. (2011). Examination of intra and interrater reliability with a new ultrasonographic reference atlas for scoring of synovitis in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. 70(11). 1995–1998. 130 indexed citations

5.

Hopf, U., V. König, Thomas Berg, et al.. (1994). [Long-term follow-up of chronic hepatitis C after treatment with recombinant interferon alpha-2a].. PubMed. 32(8). 425–30. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact